JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266276

Human TECR (GPSN2) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TECR KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 1.

View Alternative Names

2410016D23Rik, A230102P12Rik, AI173355, D17Ertd178e, Glycoprotein synaptic 2, Gpsn2, Neuroprotective protein 13, SC2, Synaptic glycoprotein SC2, TER, Trans 2,3 enoyl CoA reductase

2 Images
Sanger Sequencing - Human TECR (GPSN2) knockout HEK-293T cell line (AB266276)
  • Sanger seq

Unknown

Sanger Sequencing - Human TECR (GPSN2) knockout HEK-293T cell line (AB266276)

Homozygous : 2 bp deletion in exon 1

Cell Culture - Human TECR (GPSN2) knockout HEK-293T cell line (AB266276)
  • Cell Culture

Lab

Cell Culture - Human TECR (GPSN2) knockout HEK-293T cell line (AB266276)

Representative images TECR knockout HEK293T cells, low and high confluency examples (top left and right respectively) and wild-type HEK293T cells, low and high confluency (bottom left and right respectively) showing typical adherent, epithelial-like morphology. Images were captured at 10X magnification using a EVOS M5000 microscope.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266276-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266276 Human TECR (GPSN2) knockout HEK-293T cell line", "number":"AB266276-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266276-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266276 Human TECR (GPSN2) knockout HEK-293T cell line", "number":"AB266276-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TECR
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The GPSN2 protein also known as Glycoprotein Subunit N2 plays an important role in the regulation of cellular processes. It has an approximate molecular mass of 45 kDa. GPSN2 is expressed in various tissues including the liver kidney and heart reflecting its involvement in different physiological contexts. This protein is involved in the post-translational modification of proteins specifically in N-linked glycosylation which is fundamental for proper protein folding and stability.
Biological function summary

GPSN2 is involved in the biosynthetic machinery as part of the oligosaccharyltransferase complex. This complex is responsible for the transfer of a glycan group to nascent polypeptides in the endoplasmic reticulum. GPSN2 contributes to efficient protein maturation ensuring that proteins acquire their correct conformations and functions. Its presence in this complex indicates important cell functions especially those involving protein processing and trafficking.

Pathways

GPSN2 takes part in the protein glycosylation pathway. This pathway is fundamental for various aspects of cell physiology including cell-cell communication and immune response. GPSN2 interacts with other proteins like STT3A and STT3B which are also components of the oligosaccharyltransferase complex. These interactions highlight its role in the glycosylation pathway influencing cellular homeostasis and signaling.

GPSN2 is associated with congenital disorders of glycosylation (CDG) and liver fibrosis. Structural abnormalities in GPSN2 can lead to CDG characterized by a wide range of developmental and metabolic issues. Additionally GPSN2's involvement in liver fibrosis links it to aberrant protein glycosylation which can exacerbate the progression of this liver disease. In these disorders GPSN2 often interacts with other glycosylation-related proteins such as the aforementioned STT3A further impacting disease development and progression.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com